Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novo Nordisk A/S
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female, age at least 18 years and below 80 years at the time of signing informed consent
Subjects diagnosed type 2 diabetes mellitus and treated with metformin monotherapy at a stable dose of at least 1500 mg daily or maximum tolerated dose above or equal to 1000 mg daily for at least 60 days prior to screening
HbA1c 7.0-10.0% (both inclusive)
Body mass index below or equal to 45.0 kg/m\^2
History of chronic pancreatitis or idiopathic acute pancreatitis
Any chronic disorder or severe disease which at the discretion of the investigator might jeopardise subject's safety or compliance with the protocol
Screening calcitonin value above or equal to 50 ng/l
Personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
Diagnosis of malignant neoplasm in the previous 5 years (except basal cell skin cancer or squamous cell skin cancer)
Any contraindications to liraglutide, sitagliptin or metformin according to local labelling